Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12123640rdf:typepubmed:Citationlld:pubmed
pubmed-article:12123640lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:12123640lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:12123640lifeskim:mentionsumls-concept:C0035331lld:lifeskim
pubmed-article:12123640lifeskim:mentionsumls-concept:C1417746lld:lifeskim
pubmed-article:12123640lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:12123640pubmed:issue1lld:pubmed
pubmed-article:12123640pubmed:dateCreated2002-7-18lld:pubmed
pubmed-article:12123640pubmed:abstractTextProtein myristoylation occurs when the 14 carbon fatty acid, myristic acid, is covalently attached by amide linkage to a protein's N -terminal glycine by an N -terminal myristoyltransferase (NMT). A variation of this called heterogeneous acylation occurs in vivo only in retina when specific proteins are modified by myristic acid (14:0), tetradecenoic acid (14:1 n-9), tetradecadienoic acid (14:2n -6), and lauric acid (12:0). Myristic and lauric acids are relatively rare, comprising approximately 1% of the fatty acids in the retina. The unsaturated fatty acids 14:1 n-9 and 14:2 n-6 are less abundant, but can be synthesized in retina by retroconversion of 18:1 n-9 and 18:2 n-6 fatty acids, respectively. A previous quantitative study of acyl-CoA pools in bovine retina, heart, and liver found comparable levels of acyl-CoAs in each tissue, indicating that heterogeneous acylation is not due to limiting amounts of myristoyl-CoA in retina. In this current study the authors have characterized a panel of purified recombinant Type I and II NMTs found in retina and liver by assessing their utilization of the four acyl-CoAs used in vivo to acylate retina proteins. Acceptor peptides used in these assays were derived from the N -termini of src which is only myristoylated in vivo, and the cAMP dependent kinase A catalytic subunit which is heterogeneously acylated in retina, but myristoylated in other tissues. The authors have tested the ability of unlabelled acyl-CoAs to compete with [(3)H] myristoyl-CoA transfer, the efficacy of an NMT inhibitory protein (NIP(71)), and acyl-CoA affinity chromatography was used to isolate endogenous NMT inhibitory factor(s) from bovine heart and retina tissue homogenates. These results provide a basis of kinetic parameters and enzymatic characterization for Type I and Type II NMTs with two acceptor peptides and the four physiologically relevant fatty acid-CoAs found on retinal proteins, but do not indicate that heterogeneous acylation is a specialized function of any of the enzymes tested in this study.lld:pubmed
pubmed-article:12123640pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12123640pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12123640pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12123640pubmed:languageenglld:pubmed
pubmed-article:12123640pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12123640pubmed:citationSubsetIMlld:pubmed
pubmed-article:12123640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12123640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12123640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12123640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12123640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12123640pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12123640pubmed:statusMEDLINElld:pubmed
pubmed-article:12123640pubmed:monthJullld:pubmed
pubmed-article:12123640pubmed:issn0014-4835lld:pubmed
pubmed-article:12123640pubmed:authorpubmed-author:RajalaRaju...lld:pubmed
pubmed-article:12123640pubmed:authorpubmed-author:AndersonRober...lld:pubmed
pubmed-article:12123640pubmed:authorpubmed-author:RundleDana...lld:pubmed
pubmed-article:12123640pubmed:issnTypePrintlld:pubmed
pubmed-article:12123640pubmed:volume75lld:pubmed
pubmed-article:12123640pubmed:ownerNLMlld:pubmed
pubmed-article:12123640pubmed:authorsCompleteYlld:pubmed
pubmed-article:12123640pubmed:pagination87-97lld:pubmed
pubmed-article:12123640pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:12123640pubmed:meshHeadingpubmed-meshheading:12123640...lld:pubmed
pubmed-article:12123640pubmed:meshHeadingpubmed-meshheading:12123640...lld:pubmed
pubmed-article:12123640pubmed:meshHeadingpubmed-meshheading:12123640...lld:pubmed
pubmed-article:12123640pubmed:meshHeadingpubmed-meshheading:12123640...lld:pubmed
pubmed-article:12123640pubmed:meshHeadingpubmed-meshheading:12123640...lld:pubmed
pubmed-article:12123640pubmed:meshHeadingpubmed-meshheading:12123640...lld:pubmed
pubmed-article:12123640pubmed:meshHeadingpubmed-meshheading:12123640...lld:pubmed
pubmed-article:12123640pubmed:meshHeadingpubmed-meshheading:12123640...lld:pubmed
pubmed-article:12123640pubmed:meshHeadingpubmed-meshheading:12123640...lld:pubmed
pubmed-article:12123640pubmed:meshHeadingpubmed-meshheading:12123640...lld:pubmed
pubmed-article:12123640pubmed:meshHeadingpubmed-meshheading:12123640...lld:pubmed
pubmed-article:12123640pubmed:year2002lld:pubmed
pubmed-article:12123640pubmed:articleTitleCharacterization of Type I and Type II myristoyl-CoA:protein N-myristoyltransferases with the Acyl-CoAs found on heterogeneously acylated retinal proteins.lld:pubmed
pubmed-article:12123640pubmed:affiliationDepartment of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, U.S.A.lld:pubmed
pubmed-article:12123640pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12123640pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12123640pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12123640lld:pubmed